SANTA BARBARA, Calif., Dec. 14 /PRNewswire/ -- Izalex Incorporated today announced the appointment of Tom Proulx as a director of the board effective immediately. Mr. Proulx, a co-founder of Intuit, Inc. and inventor of the successful financial software program Quicken(TM) will join Dr. Gary Lynch, professor-above-scale at UC Irvine and R. Scott Greer on the Izalex board of directors.
“Tom brings to the Izalex Board an abundance of entrepreneurial experience and specifically first-hand knowledge of customer friendly software development,” said R. Scott Greer, Chairman and CEO of Izalex. “Tom’s expertise will be a significant advantage as we finalize design and implementation of the NeuroGraph software. In addition, Tom’s business experience with technology startups compliments that of the other directors.”
Mr. Proulx was a pioneer in the consumer software products industry as the author of Quicken and co-founder of Intuit, Inc., which he started during his senior year at Stanford University in 1983. After retiring from Intuit in 1994, Mr. Proulx is now a private investor in technology startup companies. He has been a director on the boards of numerous tech startups, including UpShot (acquired by Siebel Systems, Inc.), Documagix (acquired by J2 Global Communications, Inc.), and NextSet (acquired by Australian company, IT&e Limited). Mr. Proulx currently serves as Chairman of Netpulse, LLC, a manufacturer of touch-screen computers that attach to health club exercise equipment, enabling users to surf the web, watch personal TV, and listen to music while exercising. Among his professional honors, Mr. Proulx has been a recipient of the Inc. Magazine Entrepreneur of the Year Award, PC Letter’s Hindsight Award, and the University of Southern California’s Entrepreneur of the Year Award.
About Izalex
Izalex was formed to develop and commercialize innovative medical devices that assist physicians in diagnosing and treating psychiatric disorders. The company’s product portfolio is based on its proprietary NeuroGraph(R) technology. The NeuroGraph is a portable, turnkey hardware and software system that enables a doctor to run an approximately 20 minute, non-invasive session eliciting detailed electrophysiological data from a patient. Powered by proprietary analytical algorithms, the NeuroGraph compares the patient’s response to proprietary databases of normal and patient populations. The software then outputs a diagnostic classification of the patient with a high degree of accuracy. More information on the company and its principals can be found at the company website http://www.izalex.com/.
Izalex Incorporated
CONTACT: R. Scott Greer, Chairman and CEO of Izalex, +1-805-969-9395,scott.greer@izalex.com
Web site: http://www.izalex.com/